Oxytocin drip during C-section labor to help maintain contractions
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re having a C-section because your labor was started (induced) or strengthened (augmented)
- You received oxytocin for at least 3 hours before your C-section
- You agree to sign written informed consent for the study
- You can safely receive neuraxial anesthesia (spinal/epidural)
- You do not have an oxytocin allergy or severe heart problems/high blood pressure history
- You are not having placenta previa or carrying more than one baby
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
This trial compares giving oxytocin as a single injection versus a slow drip during C-sections in people at high risk for heavy bleeding after delivery. The goal is to find which method works better to prevent postpartum hemorrhage.
This study compares two ways of giving oxytocin (a medicine to help the uterus contract) during a planned C-section under spinal anesthesia. It aims to see which method keeps blood pressure more stable.
This trial compares two medication approaches to prevent excessive bleeding during planned cesarean delivery under spinal anesthesia. Researchers want to see if one medication (carbetocin) works as well as carbetocin combined with a second medication (oxytocin).
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This trial tests whether taking a break from oxytocin (a medicine used to strengthen contractions) can help reduce the chance of needing a C-section. It is for women whose labor has slowed down despite oxytocin.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.